Nuclear Medicine/Radiopharmaceutical Market by Type (Diagnostics, Therapeutics), Application (Oncology, Cardiology, Thyroid), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027

  • Publish Date: Feb, 2020
  • Report ID: 411518
  • Category: Healthcare
  • Pages: 240
$4700

The global Nuclear medicine/radiopharmaceutical market is expected to grow from USD 4.21 billion in 2019 to USD 7.17 billion by 2027, at a CAGR of 6.90% during the forecast period from 2020 to 2027. Increasing incidence of cancer and cardiac ailments across the globe is the major driver of the market. Nuclear medicine shows huge potential for treating cancer and cardiac diseases. In addition to this, increasing use of single-photon emission computed tomography (SPECT) and positron-emission tomography (PET) scans, technological advancements in equipment, increased utilization of fusion imaging, and new radiopharmaceuticalals for oncology applications, are some of the key driving factors further boosting the growth of market. However, short half-life of radiopharmaceuticalals, budgets constraints of hospitals, and high equipment prices, could hamper the market growth over the forecast period.

The study delivers a comprehensive analysis of types, applications, and regions. Type segment includes diagnostics and therapeutics. The diagnostics segment accounted for the major market share of 74.93% in 2019. Diagnostic procedures using radioisotopes are becoming more routine due to the valuable information they can provide, boosting the growth of this segment. The application segment is classified into oncology, cardiology, and thyroid. The oncology segment held the major market share and valued at USD 2.06 billion in 2019. Nuclear medicine offers screening methods for oncology such as bone and bone marrow scintigraphy and also used for detection of oncology such as staging of esophageal, gastric, cervical, and non-small-cell lung cancer as well as for head and neck carcinomas and lymphoma. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. North America held the largest market share of 44.27% in 2019. This is attributed to early adoption of nuclear medicines, increasing SPECT and PET applications, and high public awareness for thyroid and oncology across the region. In North America, U.S. has holds more than 80% of the market for diagnostic radioisotopes.

Key players in the Nuclear medicine/radiopharmaceutical market are China lsotope & Radiation Corporation, Yantai Dongcheng Biochemicals Co., Ltd, Philips Healthcare Informatics, Inc, Cardinal Health, Inc., Mallinckrodt Pharmaceuticals, GEHealthcare, Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A , Bayer AG , Eczacıbaşı Monrol Nükleer Ürünler Tic. ve San A.Åž. , Nordion (Canada) Inc., Advanced Accelerator Applications, and Curium  among others. Developing and developed countries are offering greater opportunities and major players are continuously focused on new developments, strategic partnerships, acquisitions and venture capital investments to obtain high growth in the market. In April 2018, Curium announced that it has signed an agreement to acquire Cyclopharma’s manufacturing and commercial operations in France, to provide a more comprehensive footprint and a significantly enhanced reliability to Curium portfolio of PET tracers to customers and patients across France.

This study forecasts revenue growth at global, regional, and country levels from 2013 to 2027. Fior Markets has segmented on the basis of below-mentioned segments:

  • Global Nuclear Medicine/Radiopharmaceutical Market Analysis And Forecast, By Type
    • Diagnostics
    • Therapeutics
  • Global Nuclear Medicine/Radiopharmaceutical Market Analysis And Forecast, By Applications
    • Oncology
    • Cardiology
    • Thyroid
  • Global Nuclear Medicine/Radiopharmaceutical Market Analysis And Forecast, By Regional Analysis
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • Sweden
      • Netherland
      • U.K.
      • Italy
      • Spain
      • Turkey
      • Switzerland
      • Belgium
      • Rest Of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • South Korea
      • Australia
      • Singapore
      • Malaysia
      • Thailand
      • Indonesia
      • Philippines
      • Rest Of APAC
    • South America
      • Brazil
      • Argentina
      • Peru
      • Colombia
      • Rest Of South America
    • Middle East And Africa
      •  UAE
      •  Saudi Arabia
      •  Egypt
      •  Nigeria
      •  South Africa
      • Rest Of MEA

Chapter 1 Introduction 21
    1.1 Research Methodology 21
    1.2 FMR desk research 22
          1.2.1 FMR data synthesis 23
          1.2.2 Data validation and market feedback 23
          1.2.3 FMR data sources 24
 

Chapter 2 Global Nuclear Medicine/Radiopharmaceutic Market Overview 26
    2.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic 26
    2.2 Commercial Types of Nuclear Medicine/Radiopharmaceutic 29
          2.2.1 Diagnostic 30
          2.2.2 Therapeutic 32
    2.3 Commercial Material Application of Nuclear Medicine/Radiopharmaceutic 41
          2.3.1 Oncology 42
          2.3.2 Thyroid 43
          2.3.3 Cardiology 44
          2.3.4 Development History of Nuclear Medicine/Radiopharmaceutic 46
    2.4 Market Status and Trend of Nuclear Medicine/Radiopharmaceutic 2013-2027 54
    2.5 Regional Nuclear Medicine/Radiopharmaceutic Market Status and Trend 2013-2027 56
          2.5.1 North America Market Status and Trend 2013-2027 56
          2.5.2 Europe Market Status and Trend 2013-2027 59
          2.5.3 Asia Pacific Market Status and Trend 2013-2027 61
          2.5.4 Middle East and Africa Market Status and Trend 2013-2027 65
          2.5.5 Latin America Market Status and Trend 2013-2027 67
 

Chapter 3 Global Market Status by Regions 69
    3.1 Market Development of Nuclear Medicine/Radiopharmaceutic 2013-2017 69
    3.2 Production Market of Nuclear Medicine/Radiopharmaceutic by Regions 70
          3.2.1 Regions Revenue of Nuclear Medicine/Radiopharmaceutic by Regions 70
    3.3 Market Development of Nuclear Medicine/Radiopharmaceutic 2013-2017 75
    3.4 Procedural Volume of Nuclear Medicine/Radiopharmaceutic by Regions 76
          3.4.1 Regions Procedural Volume of Nuclear Medicine/Radiopharmaceutic by Regions 76
    3.5 Nuclear Medicine/Radiopharmaceutic Price (USD)(Diagnostics and Therapeutics) by Regions 2013-2017 81
    3.6 Market Forecast of Nuclear Medicine/Radiopharmaceutic by Regions 2018-2027 82
    3.7 Market Forecast of Nuclear Medicine/Radiopharmaceutic by Regions 2018-2027 84
    3.8 Nuclear Medicine/Radiopharmaceutic Price (Diagnostics and Therapeutics ) by Regions 2018-2027 86
 

Chapter 4 Global Nuclear Medicine/Radiopharmaceutic Production by Type 87
    4.1 Revenue (USD Mn) and Procedural Volume (Thousand) of Nuclear Medicine/Radiopharmaceutic by Types 87
          4.1.1 Revenue (USD Mn) of Nuclear Medicine/Radiopharmaceutic by Types 87
          4.1.2 Procedural Volume (Thousand) of Nuclear Medicine/Radiopharmaceutic by Types 92
                   4.1.2.1 Revenue of Nuclear Medicine/Radiopharmaceutic by Diagnostics Types 97
                   4.1.2.2 Procedural Volume of Nuclear Medicine/Radiopharmaceutic by Diagnostics Types 106
                   4.1.2.3 Revenue of Nuclear Medicine/Radiopharmaceutic by Therapeutics Types 115
                   4.1.2.4 Procedural Volume of Nuclear Medicine/Radiopharmaceutic by Therapeutics Types 119
    4.2 Procedural Price of Nuclear Medicine/Radiopharmaceutic by Types 123
    4.3 Revenue (USD Mn) of Nuclear Medicine/Radiopharmaceutic by Types Forecast 124
    4.4 Procedural Volume (Thousand) of Nuclear Medicine/Radiopharmaceutic by Types Forecast 128
                   4.4.1.1 Revenue of Nuclear Medicine/Radiopharmaceutic by Diagnostics Types 132
                   4.4.1.2 Procedural Volume of Nuclear Medicine/Radiopharmaceutic by Diagnostics Types 141
    4.5 Market Forecast of Nuclear Medicine/Radiopharmaceutic by Types 150
    4.6 Market Forecast of Nuclear Medicine/Radiopharmaceutic by Types 153
 

Chapter 5 Global Market Status by Downstream Industry 156
    5.1 Demand Value of Nuclear Medicine/Radiopharmaceutic by Downstream Industry 156
    5.2 Procedural Volume of Nuclear Medicine/Radiopharmaceutic by Downstream Industry 161
    5.3 Market Forecast of Nuclear Medicine/Radiopharmaceutic by Downstream Industry 166
    5.4 Market Forecast of Nuclear Medicine/Radiopharmaceutic by Downstream Industry 168
 

Chapter 6 Nuclear Medicine/Radiopharmaceutic Market Competition Status by Major Manufacturers 170
    6.1 Revenue of Nuclear Medicine/Radiopharmaceutic by Major Manufacturers 170
    6.2 Market Competition News and Trend 174
 

Chapter 7 Market Driving Factor Analysis of Nuclear Medicine/Radiopharmaceutic 178
    7.1 Global Economy Situation and Trend Overview 178
          7.1.1 Improvements in current modalities 178
          7.1.2 Development of new tracers 178
          7.1.3 Development of new treatments 179
          7.1.4 Personalized medicine 179
          7.1.5 Development of new equipment and modalities 180
    7.2 Plant Location and Established Time of Nuclear Medicine/Radiopharmaceutic Major Manufacturer 181
    7.3 Employees and Revenue Level of Nuclear Medicine/Radiopharmaceutic Major Manufacture 182
 

Chapter 8 Nuclear Medicine/Radiopharmaceutic Major Manufacturers 183
    8.1 China lsotope & Radiation Corporation. (is the holding subsidiary of China National Nuclear Corporation(CNNC)) 183
          8.1.1 Company Profile 183
          8.1.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 185
    8.2 Yantai Dongcheng Biochemicals Co., Ltd 186
          8.2.1 Company Profile 186
          8.2.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 188
    8.3 Philips Healthcare Informatics, Inc. 189
          8.3.1 Company Profile 189
          8.3.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 191
    8.4 Cardinal Health 192
          8.4.1 Company Profile 192
          8.4.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 194
          8.4.3 Nuclear Medicine/Radiopharmaceutic Industry Sales, Revenue, Price and Gross Margin of Cardinal Health 196
    8.5 Mallinckrodt Pharmaceuticals 197
          8.5.1 Company Profile 197
          8.5.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 199
    8.6 GEHealthcare 200
          8.6.1 Company Profile 200
          8.6.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 202
          8.6.3 Nuclear Medicine/Radiopharmaceutic Industry Sales, Revenue, Price and Gross Margin of GEHealthcare 203
    8.7 Lantheus Medical Imaging, Inc. (operates as a subsidiary of Lantheus Holdings, Inc) 204
          8.7.1 Company Profile 204
          8.7.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 206
          8.7.3 Nuclear Medicine/Radiopharmaceutic Industry Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging, Inc. 208
    8.8 Bracco Imaging S.p.A 209
          8.8.1 Company Profile 209
          8.8.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 211
          8.8.3 Nuclear Medicine/Radiopharmaceutic Industry Sales, Revenue, Price and Gross Margin of Bracco Imaging S.p.A 212
    8.9 Bayer AG 213
          8.9.1 Company Profile 213
          8.9.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 216
          8.9.3 Nuclear Medicine/Radiopharmaceutic Industry Sales, Revenue, Price and Gross Margin of Bayer AG 217
    8.10 Eczacıbaşı Monrol Nükleer Ürünler Tic. Ve San A.Åž. 218
          8.10.1 Company Profile 218
          8.10.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 221
    8.11 Nordion (Canada) Inc. (subsidiary of Sotera Health LLC) 223
          8.11.1 Company Profile 223
          8.11.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 225
    8.12 Advanced Accelerator Applications (operates as a subsidiary of Novartis Groupe France S.A.) 226
          8.12.1 Company Profile 226
          8.12.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 228
    8.13 Curium 231
          8.13.1 Company Profile 231
          8.13.2 Representative Nuclear Medicine/Radiopharmaceutic Industry Product 232
 

Chapter 9 Upstream and Downstream Market Analysis of Nuclear Medicine/Radiopharmaceutic 234
          9.1.1 Representative Consumers of Nuclear Medicine/Radiopharmaceutic by Industry 234
    9.2 Downstream Market and Representative Companies 236
          9.2.1 Oncology Market Analysis 236
          9.2.2 Thyroid Market Analysis 236
          9.2.3 Cardiology Market Analysis 237
    9.3 Distributors/Traders List 239
 

Chapter 10 Research Findings 240


1

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


+1

Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.